The company was incorporated as Thyrocare Technologies Limited on January 28, 2000 at Mumbai and received certificate of commencement of business on March 7, 2000. It was incorporated as a public limited company under the Companies Act, 1956. It is India’s first fully automated diagnostic laboratory having its strong presence in more than 2000 cities / towns in India and internationally. The company offered 192 tests and 54 profiles of tests to detect a number of disorders, including thyroid disorders, growth disorders, metabolism disorders, auto-immunity, diabetes, anemia, cardiovascular disorders, infertility and various infectious diseases.
Its profiles of tests include 17 profiles tests- administered under its “Aarogyam” brand, which offers patients a suite of wellness and preventive health care tests. It primarily operates its testing services through a fully-automated CPL and has recently expanded its operations to include a network of RPLs. Through its wholly owned subsidiary, NHL, the company operates a network of molecular imaging centers in New Delhi, Navi Mumbai and Hyderabad, focused on early and effective cancer monitoring. Through NHL, the company is developing a growing network of molecular imaging centers, which focuses primarily on early and effective cancer monitoring. Each of its imaging centers use PET-CT scanners to assist in cancer diagnosis, staging, monitoring of treatment, and efficacy and evaluation of disease recurrence.
Its CPL, which is located in Navi Mumbai, is equipped with automated systems, diagnostic testing instruments and processes from leading international and Indian healthcare brands. The CPL is fully automated and driven by a barcoded and bi-directionally-interfaced system and an LIS. The CPL meets international standards of quality and has received global accreditations from CAP, the NABTCL and the ISO.
Business area of the company
The company is one of the leading pan-India diagnostic chains and conducts an array of medical diagnostic tests and profiles of tests that center on early detection and management of disorders and diseases.
Major events and milestones